The research, led by Pooja Rao of Penn State Health Children’s Hospital and colleagues, took a convergent mixed-methods approach to understanding how young cancer survivors experience the economic fallout of their disease. The team recruited 35 adolescent and young adult cancer survivors, or AYACS, all diagnosed between ages 15 and 25 and within six years of their diagnosis. Each participant completed the Comprehensive Score for Financial Toxicity, a validated 11-item questionnaire scored from 0 to 44 where lower scores indicate worse financial distress, and then sat for a 30 to 45 minute semistructured videoconference interview about their financial experiences.

On paper, the quantitative results looked reassuring. The mean COST score was 30.4 with a standard deviation of 7.26, ranging from 16 to 43. No participant fell into the severe financial toxicity category, and 77 percent reported little to no financial toxicity at all. When the researchers ran two-sample t-tests and Fisher’s exact tests comparing scores by sex, age at diagnosis, and treatment phase, they found no statistically significant differences across any demographic variable. By conventional statistical standards, the group looked uniformly fine.

But the interviews told a very different story. Using a phenomenological thematic analysis coded independently by two analysts with an interrater reliability coefficient above 0.7, the team uncovered four distinct themes that the numbers alone had missed. The first concerned family dynamics: financial situations related to cancer treatment generated varying levels of support and conversation within families, with younger participants often shielded from the full picture. The second theme revealed that financial strain was significant for participants of all ages and directly impacted future planning. The third captured a striking split in institutional experience, where participants expressed deep gratitude for philanthropic funding while reporting mixed experiences with insurance. The fourth showed that some participants carried stressful emotions like guilt and worry about money, while others, often those with strong support systems, did not.

The most consequential divergence emerged between younger and older survivors. Participants diagnosed before age 22 at this institution were eligible for philanthropic funding that covered supportive care services, financial vouchers, medication, and test costs not paid by insurance. Younger participants described this safety net in vivid terms. One survivor of Hodgkin lymphoma recalled never seeing a bill because everything was routed directly to institutional funding. Another, an acute lymphoblastic leukemia patient, explained that because everything was paid for, the only thing they needed to worry about was their education, not a job to finance it.

Older participants, by contrast, frequently described being entirely self-sufficient during treatment, and some even found themselves supporting family members while battling their own disease. One 22 to 25 year old participant receiving treatment for Hodgkin lymphoma stated plainly that they were completely dependent on themselves and that certain family members actually relied on them when times were hard. This inversion of the expected support structure, where the patient becomes the provider, represents a dimension of financial toxicity that standard questionnaires simply do not capture.

The interviews also surfaced the phenomenon of job lock, the practice of staying in a job specifically to retain work-related health insurance. One participant completing treatment for acute lymphoblastic leukemia described weighing a return to school against the loss of employer-provided long-term disability insurance and income, ultimately concluding the risk was not worth taking. Fertility preservation emerged as another acute financial pressure point, with one breast cancer patient describing how insurance covered none of the preservation costs and how a failed first attempt forced a second round of expenses the family had not budgeted for.

The disconnect between the quantitative and qualitative findings is itself a scientific result. The authors argue that COST, while validated in adults with cancer and increasingly used with AYACS populations, may not adequately capture the unique financial challenges of young survivors, including financial independence, social consequences, and psychological impacts. Notably, the qualitative data revealed social support as a protective factor against financial toxicity, a construct COST does not measure well. The team suggests future quantitative instruments for AYACS should incorporate questions about social supports and social networks. Descriptively, the trends pointed in a concerning direction even without statistical significance: 38.5 percent of those diagnosed at ages 22 to 25 had moderate financial toxicity compared with 13.6 percent of those diagnosed at 15 to 21, and 27.3 percent of those who had completed treatment showed moderate toxicity versus 15.4 percent of those still receiving it.

The broader context amplifies these findings. Prior research cited in the study found that nearly 54 percent of AYACS aged 18 to 39 had COST scores below 26, indicating moderate or severe financial toxicity, associated with reduced quality of life, depleted savings, and medication nonadherence. Worse financial toxicity among young survivors is linked to higher depressive and anxiety symptoms and lower self-efficacy, which in turn can generate additional medical expenditures and deepen the financial hole. Survivors are also less likely to complete school, with downstream effects on workforce productivity and lifetime earnings, and cancer patients face elevated bankruptcy risk compared with those without a cancer diagnosis.

The authors acknowledge important limitations. The study was single-center, predominantly White and non-Hispanic, and skewed toward hematologic malignancies, with leukemias and lymphomas representing 74.3 percent of diagnoses. All participants self-reported being insured, and the small sample of 35 limited statistical power, making the quantitative results exploratory. The institutional philanthropic funding available to younger patients may have disproportionately buffered them compared with older peers. Still, the central message stands: young cancer survivors across sex, age, and treatment phase experience financial challenges, and the social architecture around them, family, philanthropy, insurance, determines whether that burden becomes a footnote or a defining constraint on their adult lives. The researchers call for improved services, particularly for older AYACS, and for measurement tools sensitive enough to see what survivors themselves already know.

Subject of Research: Financial toxicity and its social and psychological impacts on adolescent and young adult cancer survivors

Article Title: The impact of financial toxicity on adolescent/young adult cancer survivors (AYACS): A mixed methods study

Article References: Rao, P., Bingen, K., Devine, K. A., Segel, J. E., Wasserman, E., Rumbaugh, C., King, T. S., Costigan, H. J., Scott, A. M., Dandekar, S., Rakszawski, K., Songdej, N., Blackall, G. F., Lengerich, E. J., & Van Scoy, L. J. (2026). The impact of financial toxicity on adolescent/young adult cancer survivors (AYACS): A mixed methods study. Supportive Care in Cancer, 34(9), Article 921. https://doi.org/10.1007/s00520-026-11093-z

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11093-z

Keywords: financial toxicity, adolescent and young adult cancer survivors, COST measure, mixed methods research, cancer survivorship, job lock, health insurance, philanthropic funding, social support, fertility preservation, psychological health, Supportive Care in Cancer